DDX53 and colonic neoplasm: The results of the in vivo antitumor experiments showed that HA-NPs-PTC209 significantly inhibited the growth and metastasis of CT26 orthogonal xenografts, which led to the in situ colon tumor accumulation in in situ colon tumors, thus reversing CSC stemness.